Northern Trust’s Aethlon Medical AEMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-7
Closed -$6.39K 4472
2023
Q3
$6.39K Hold
7
﹤0.01% 4422
2023
Q2
$10.2K Hold
7
﹤0.01% 4476
2023
Q1
$10.8K Hold
7
﹤0.01% 4515
2022
Q4
$7.79K Buy
7
+2
+40% +$3.65K ﹤0.01% 4598
2022
Q3
$13K Hold
5
﹤0.01% 4609
2022
Q2
$24K Hold
5
﹤0.01% 4593
2022
Q1
$31K Hold
5
﹤0.01% 4611
2021
Q4
$40K Hold
5
﹤0.01% 4625
2021
Q3
$83K Hold
5
﹤0.01% 4444
2021
Q2
$106K Hold
5
﹤0.01% 4349
2021
Q1
$44K Buy
5
+2
+67% +$19.2K ﹤0.01% 4394
2020
Q4
$30K Hold
3
﹤0.01% 4287
2020
Q3
$16K Hold
3
﹤0.01% 4233
2020
Q2
$25K Hold
3
﹤0.01% 4137
2020
Q1
$16K Buy
+3
New +$25.4K ﹤0.01% 4109
2019
Q4
Hold
0
-$6K 4260
2019
Q3
Hold
0
4208
2019
Q2
Hold
0
4204
2019
Q1
Hold
0
4110
2018
Q4
Hold
0
4067
2018
Q3
Hold
0
4183
2018
Q2
Hold
0
4167
2018
Q1
Hold
0
4130
2017
Q4
Hold
0
4146
2017
Q3
Hold
0
4131
2017
Q2
Hold
0
4118
2017
Q1
Hold
0
4053
2016
Q4
Hold
0
4005
2016
Q3
Hold
0
3981
2016
Q1
Hold
0
-$77K 4250
2015
Q4
Hold
0
3985
2015
Q3
Hold
0
3979

Other funds holding AEMD

Northern Trust's AEMD Position: Q4 2023 in Review

Northern Trust sold out of Aethlon Medical (AEMD) in Q4 2023, closing a stake of 7 shares — an estimated $6.39K sold.

Northern Trust first reported a position in AEMD in Q1 2020 and held it in 15 quarters. The position peaked at $106K in Q2 2021. 7 funds tracked by Wall St. Rank hold AEMD as of Q4 2023.

  • Northern Trust reported no remaining Aethlon Medical position as of Q4 2023 after selling out during the quarter.
  • Northern Trust sold 7 Aethlon Medical shares in Q4 2023, an estimated $6.39K.
  • Northern Trust first reported a position in Aethlon Medical in Q1 2020 and held it in 15 quarters.
  • Northern Trust's Aethlon Medical position peaked at $106K in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Aethlon Medical as of Q4 2023.

Based on Northern Trust's 13F filing for Q4 2023, filed 13 Feb 2024.